Safety evaluation of penfluridol, a new long-acting oral antipsychotic agent.
D000284:Administration, Oral; D000328:Adult; D001519:Behavior / Q000187:drug effects; D001590:Benztropine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D004361:Drug Tolerance; D004562:Electrocardiography; D005123:Eye / Q000187:drug effects; D006801:Humans; D006846:Hydrocarbons, Halogenated / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use; D008875:Middle Aged; D010880:Piperidines / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D011569:Psychiatric Status Rating Scales; D011618:Psychotic Disorders / Q000188:drug therapy*; D012559:Schizophrenia / Q000188:drug therapy; D013997:Time Factors; D014050:Toluene / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use; D014149:Tranquilizing Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*
D006846:Hydrocarbons, Halogenated; D010880:Piperidines; D014149:Tranquilizing Agents; D001590:Benztropine; D014050:Toluene